RAP
Click for more information
0.00% 20.5¢ resapp health limited

Ann: ResApp Announces Expanded Research Collaboration with MGH, page-14

  1. adamoto
    213 Posts.
    lightbulb Created with Sketch. 14
    clock Created with Sketch.
    10/01/17
    09:45
    Post #: 21784532
    I doubt this will affect FDA timeline as it is additional research outside of that parameter... however it might be best to ask and clarify with management if people are unsure and instead of creating uncertainties
    RAP Price at posting: 36.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.